Detroit, United States
Functional Fluidics is a health care startup founded in 2014 and headquartered in the United States. The company's slogan "Defining Red Blood Cell Health" accurately represents its core mission. Functional Fluidics offers a unique testing platform designed to evaluate the health of red blood cells (RBCs), crucial for oxygen delivery in the body. The company's proprietary tests, including the mechanical fragility test and adhesion test, provide essential insights into RBC health, generating indices that indicate the overall health of RBCs.
Notably, the mechanical fragility index (MFI) and adhesion index serve as valuable indicators of a patient's health status. Moreover, in response to the Covid-19 pandemic, Functional Fluidics has expanded its offerings to include Covid-19 tests and Covid-19 antibody tests. This expansion aligns with the company's commitment to contributing to public health, especially in the context of workplace, school, and college reopening strategies.
The company's recent milestone includes securing a Venture Round investment at 07 December 2023 from NYBC Ventures, highlighting investor confidence in the company's innovative approach and growth potential within the health care industry. For organizations or individuals seeking comprehensive solutions related to Red Blood Cell health, Covid-19 testing, or Covid-19 antibody testing, Functional Fluidics presents a compelling option. For further information or inquiries, interested parties can visit functionalfluidics.com or contact the company at 313-315-2555.
